News

Asthma, a chronic condition that affects the airways in the lungs, can lead to a range of symptoms that interfere with daily life. While most people are familiar with the most common symptoms of asthma such as wheezing or whistling sounds, shortness of breath, chest tightness and frequent coughing, several others are not as widely recognized.

Every day for the next five years, 10,000 Baby Boomers will turn 65, and by 2030, 18 percent of the U.S. population will be age 65 or older according to the Pew Research Center. While old age certainly doesn’t begin at 65, it’s not unreasonable to think as we age, we may need help from loved ones. Millions of Americans already act as caregivers each year.

Like clockwork, two times a year — cold and flu season and allergy season — we get a tingle in our sinuses that can only mean one thing: The snot floodgates are about to open.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.

Winter’s frigid temperatures often drive us to gather indoors with family and friends, increasing the risk of developing a respiratory illness. The lessons learned from managing COVID-19 help with other winter illnesses such as colds, influenza, and respiratory syncytial virus (RSV), which can significantly affect young children. Medical experts remind us to: